Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: A pilot study

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Starkweather, Angela R ^a   Sherwood, Paula ^b   Lyon, Debra E ^c   Bovbjerg, Dana H ^b   Broaddus, William C ^d   Elswick, R K ^a   Sturgill, Jamie ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF NURSING   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 8;

ADULT; AGED; ASTROCYTOMA; BLOOD; CANCER GRADING; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMPLICATION; DEPRESSION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PILOT STUDY; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE;

ADULT; AGED; ASTROCYTOMA; CENTRAL NERVOUS SYSTEM NEOPLASMS; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPLASM GRADING; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84905391754     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-423     Document Type: Article

References (39)

1. Central Brain Tumor Registry of the United States (CBTRUS), Primary brain tumors in the United States: Fact sheet Hinsdale, IL: CBTRUS 2013
2. American Cancer Society, Cancer facts and figures, 2013 Atlanta: ACS 2013
3. Improving prognosis of glioblastoma in the 21st century: who has benefited most? Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X, Symon Z, Dicker AP, Cancer 2012 118 4228 4234
4. Depression as a prognostic factor for breast cancer mortality. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T, Psychosom 2003 44 24 30 (Pubitemid 36050569)
5. Depression and survival in patient with non-small cell lung cancer after curative resection: a preliminary study. Nakaya N, Saito-Nakaya K, Akizuki N, Yoshikawa E, Kobayakawa M, Fujimori M, Nagai K, Nishiwaki Y, Fukudo S, Tsubono Y, Uchitomi Y, Cancer Sci 2006 97 199 205
6. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A, Weingart JD, Brem H, Quinones-Hinojosa A, Surg Neurol 2009 71 299 303
7. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr, Glioma Outcomes Project Investigators, Neurosurg 2004 54 358 366
8. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P, Neurosurg 2005 56 1234 1241 (Pubitemid 40770438)
9. Decreased quality of life and depression as predictors of shorter survival among patients with low-grade gliomas: a follow up from 1990 to 2003. Mainio A, Tuunanen S, Hakko H, Niemela A, Koivukangas J, Rasanen P, Eur Arch Psychiatry Clin Neurosci 2006 256 516 521 (Pubitemid 46020526)
10. Stress influences on anoikis. Sood AK, Lutgendorf SK, Canc Prev Res 2011 4 481 485
11. Vascular endothelial growth factor and psychosocial factors in colorectal cancer. Sharma A, Greenman J, Sharp DM, Walker LG, Monson JR, Psychooncol 2008 17 66 73 (Pubitemid 351166279)
12. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R, Brain Behav Immun 2009 23 67 75
13. Twenty years of research on cytokine-induced sickness behavior. Dantzer R, Kelley KW, Brain Behav Immun 2007 21 153 160 (Pubitemid 46038917)
14. Cytokines and their role in depression. Wilson DR, Warise L, Perspect Psychiatr Care 2008 44 285 289
15. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Loftis JM, Huckans M, Morasco BJ, Neurobiol Dis 2010 37 519 533
16. Neuroplastic changes in depression: a role for the immune system. Eyre H, Baune BT, Psychoneuroendocrinol 2012 37 1397 1416
17. Understanding the role of cytokines in glioblastoma multiforme pathogenesis. Zhu VF, Yang J, LeBrun DG, Li M, Cancer Lett 2012 316 139 150
18. Immune function of astrocytes. Dong Y, Benveniste EN, Glia 2001 36 180 190 (Pubitemid 33055906)
19. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas. Brommeland T, Rosengran L, Fridlund S, Hennig R, Isaksen V, Acta Neurolog Scand 2007 116 380 384 (Pubitemid 350045499)
20. Glial fibrillary acidic protein in astrocytes in the human neocortex. Korzhevskii DE, Otellin VA, Grigor'ev IP, Neurosci Behav Physiol 2005 35 789 792 (Pubitemid 41300504)
21. Biobehavioral factors and cancer progression: Physiological pathways and mechanisms. Lutgendorf SK, Sood AK, Psychosom Med 2011 73 724 730
22. Cancer related inflammation: the macrophage connection. Sica A, Allavena P, Mantovani A, Cancer Lett 2008 267 204 215
23. Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Kumar R, Kamdar D, Madden L, Hills C, Crooks D, O'Brien D, Greenman J, Oncol Rep 2006 15 1513 1516
24. Comparative analaysis of peripheral and localized cytokine secretion in glioblastoma patients. Zisakis A, Piperi C, Themistocleous MS, Korkolopoulou P, Boviatsis EI, Sakas DE, Patsouris E, Lea RW, Kalofoutis A, Cytokine 2007 39 99 105 (Pubitemid 47513833)
25. Norepinephrine up-regulates the expression of vascular endothelia growth factor, matrix metalloproteinase MMP-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Yang EV, Sood AK, Chem M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaster R, Cancer Res 2006 66 10357 10364 (Pubitemid 44799755)
26. Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. Davis S, Thomas A, Perry R, Oakley A, Kalaria RN, O'Brien JT, J Neurol Neurosurg Psych 2002 73 556 560 (Pubitemid 35246811)
27. Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm. McCain NL, Gray DP, Walter JM, Robins J, Adv Nurs Sci 2005 28 320 332 (Pubitemid 41689507)
28. A biobehavioral perspective on depressive symptoms in patients with a cerebral astrocytoma. Starkweather AR, Sherwood P, Lyon DE, McCain NL, Bovbjerg D, Broaddus WC, J Neurosci Nurs 2011 43 1 17 28
29. Depression in cerebral glioma patients: a systematic review of observational studies. Rooney AG, Carson A, Grant R, J Natl Cancer Inst 2011 103 61 76
30. Symptom clusters in patients with high-grade glioma. Fox S, Lyon D, Farace E, J Nurs Scholarsh 2007 39 61 67
31. Depression and functional outcome in patients with brain tumors: A population-based 1-year follow-up study. Mainio A, Hakko H, Niemala A, Koivukangas J, Rasanen P, J Neurosurg 2005 103 841 847 (Pubitemid 43194578)
32. Induced interleukin-8 expression in gliomas by tumor associated macrophages. Hong TM, Teng LJ, Shun CT, Peng MC, Tsai JC, J Neurooncol 2009 93 289 301
33. Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors. Samaras V, Piperi C, Korkolopoulou P, Zisakis A, Levidou G, Themistocleous MS, Boviatsis EI, Sakas DE, Lea RW, Kalofoutis A, Patsouris E, Mol Cell Biochem 2007 304 343 351 (Pubitemid 47456883)
34. Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for glioblastoma. Ciu X, Xu Z, Zhao Z, Sui D, Ren X, Huang Q, Qin J, Hao L, Wang Z, Shen L, Lin S, Inter J Biol Sci 2013 9 134 141
35. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: The impact of the extent of resection on quality of life and survival. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC, Neurosurg 2005 57 495 504
36. Beck AT, Steer RA, Brown GK, Manual for the Beck Depression Inventory-II San Antonio, TX: Psychological Corporation 1996
37. Cohen S, Perceived stress scale Mind Garden: Palo Alto, CA 1994
38. A global measure of perceived stress. Cohen S, Kamarch T, Mermelstein R, J Health Social Behav 1983 24 385 396
39. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). Armstrong TS, Mendoza T, Gning I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C, J Neuro-Oncol 2006 80 27 35 (Pubitemid 44473259)